Thiazolo[3,4-b]isoquinoline derivatives and pharmaceutical compo

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260288CF, 260283S, 260283CN, 260289C, 260289D, 260287D, 260286R, 260283R, 2602948R, C07D51314, A61K 3147

Patent

active

040642470

ABSTRACT:
Thiazolo[3,4-b]isoquinoline derivatives of the general formula: ##STR1## wherein A represents 3-pyridyl, 4-pyridyl or 5-isoquinolyl and, when A represents 3-pyridyl, X.sub.1 represents hydrogen, halogen, dimethylamino or cyano, X.sub.2 represents hydrogen or fluorine and X.sub.3 represents hydrogen or nitro, at least two of X.sub.1, X.sub.2 and X.sub.3 representing hydrogen, or X.sub.1 X.sub.2 together represent methylenedioxy and X.sub.3 represents hydrogen, and when A represents 4-pyridyl or 5-isoquinolyl, X.sub.1, X.sub.2 and X.sub.3 each represent hydrogen, and non-toxic pharmaceutically acceptable acid addition salts thereof, possess useful pharmacodynamic properties, in particular analgesic and antipyretic activity. This invention relates to new therapeutically useful thiazolo[3,4-b]isoquinoline derivatives, to processes for their preparation and to pharmaceutical compositions containing them.

REFERENCES:
patent: 3455933 (1969-07-01), Georgiadis et al.
patent: 3979397 (1976-09-01), Harsanyi et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Thiazolo[3,4-b]isoquinoline derivatives and pharmaceutical compo does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiazolo[3,4-b]isoquinoline derivatives and pharmaceutical compo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolo[3,4-b]isoquinoline derivatives and pharmaceutical compo will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-600262

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.